IRVINE, Calif.--(BUSINESS WIRE)--May 4, 2006--Cortex Pharmaceuticals, Inc. (AMEX: COR - News), a neuroscience company focused on developing novel AMPAKINE® drug therapies for neurological and psychiatric disorders, will webcast presentations from its annual shareholder meeting scheduled for Wednesday, May 10, 2006, at 10:30 a.m., Pacific Daylight Time, at the Marriott Newport Beach Hotel, 900 Newport Center Drive, in Newport Beach, California. The informal part of the meeting will update shareholders on the latest information related to Cortex’s high and low impact drug programs and recent developments related to the clinical hold for CX717.
